Bond Screener
Glenmark Pharmaceuticals
LEI 335800WKECZXIIT9GK20
Organization name
Glenmark Pharmaceuticals Ltd
Country name
India
Country of registration
India
Industry
Pharmaceutical Preparation and Biotechnology
Credit Ratings
in foreign currency
Public debt
-
Upgrade to Premium features
Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market
Get access
-
Full access to the largest bond database
Bond parameters,
prospectuses -
Seamless
Data exportAnalyze the data in the most efficient way
-
Bond pricing
Current & historical quotes from 400+ stock exchanges & OTC market
-
Smart risk assessment
Credit ratings, financial reports
Trading Schedule Issuer map
Quotes
/
/
/
pcs.
pcs.
pcs.
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Quotes provided by information providers are indicative in nature
Profile
|
Glenmark Pharmaceuticals is a pharmaceutical company headquartered in Mumbai, India. It manufactures and markets generic formulation products and active pharmaceutical ingredients (API), both in the domestic and international markets. In the formulation business, its business spans segments such as Dermatology, Internal Medicine, Paediatrics, Gynaecology, ENT and Diabetes.
|
General information
-
Organization nameGlenmark Pharmaceuticals Ltd
-
Organization statusOperating organization
-
AddressGLENMARK HOUSE, B D SAWANT MARG, OFF WESTERN EXPRESS HIGHWAY CHAKALA, ANDHERI EAST, MUMBAI, India, 400099
-
Site
News
Stocks
General information
-
Organization nameGlenmark Pharmaceuticals Ltd
-
Organization statusOperating organization
-
AddressGLENMARK HOUSE, B D SAWANT MARG, OFF WESTERN EXPRESS HIGHWAY CHAKALA, ANDHERI EAST, MUMBAI, India, 400099
-
Site
Codes
-
LEI335800WKECZXIIT9GK20
-
SIC2834 PHARMACEUTICAL PREPARATIONS
-
ICB4,500 Health Care
-
NACE*** ***
-
NAICS*** ***
